EMERGENCE THERAPEUTICS
Emergence Therapeutics is a European biopharmaceutical company developing novel antibody-drug conjugates (ADC) to treat high-need cancers. Its lead program combines a highly specific antibody with optimized linker and payload technology to target Nectin-4 โ an important target for a broad range of cancers which has been clinically validated as an ADC target by enfortumab vedotin, now approved for the treatment of urothelial cancers by the US Food and Drug Administration. Emergence is also actively exploring opportunities to develop further first- or best-in-class ADCs driven by therapeutic need.
EMERGENCE THERAPEUTICS
Social Links:
Industry:
Biotechnology Fitness Health Care Wellness
Founded:
2019-01-01
Address:
Duisburg, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.emergencetx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
87 M EUR
Similar Organizations
Asana Rebel
Asana Rebel is a young and growing startup committed to creating highly engaging health and fitness experiences.
Clue
Clue is a female health application that tracks period and fertility cycle.
Fitternity
India's largest online fitness platform that provides an integrated eco-system to help users start & sustain their fitness journey.
TeleClinic
TeleClinic is a communication platform that enables simple and secure communication between doctors and patients all over Germany.
Current Advisors List
Current Employees Featured
Founder
Investors List
Surveyor Capital
Surveyor Capital investment in Series A - Emergence Therapeutics
Gruenderfonds Ruhr
Gruenderfonds Ruhr investment in Series A - Emergence Therapeutics
OrbiMed
OrbiMed investment in Series A - Emergence Therapeutics
Pontifax
Pontifax investment in Series A - Emergence Therapeutics
Bpifrance
Bpifrance investment in Series A - Emergence Therapeutics
Hadean Ventures
Hadean Ventures investment in Series A - Emergence Therapeutics
NRW.BANK
NRW.BANK investment in Series A - Emergence Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series A - Emergence Therapeutics
Kurma Partners
Kurma Partners investment in Series A - Emergence Therapeutics
RA Capital Management
RA Capital Management investment in Series A - Emergence Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-06-07 | Emergence Therapeutics strengthens leadership team with the appointment of Hatem Azim as Chief Medical Officer |
Official Site Inspections
http://www.emergencetx.com
- Host name: ec2-18-188-128-145.us-east-2.compute.amazonaws.com
- IP address: 18.188.128.145
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215